General practitioners' provision of end-of-life care and associations with dying at home: a registry-based longitudinal study.


Journal

Family practice
ISSN: 1460-2229
Titre abrégé: Fam Pract
Pays: England
ID NLM: 8500875

Informations de publication

Date de publication:
23 07 2020
Historique:
pubmed: 30 1 2020
medline: 11 8 2021
entrez: 30 1 2020
Statut: ppublish

Résumé

General practitioners (GPs) may play an important role in providing end-of-life care to community-dwelling people. To investigate patients' contacts with GPs, GPs' interdisciplinary collaboration, out-of-hours services and hospitalizations in the last 13 weeks of life and associations with dying at home. Second, investigate whether GP contacts were associated with fewer out-of-hours contacts or days hospitalized. Individually linked data from the Norwegian Cause of Death Registry, Norwegian Patient Registry, Statistics Norway and Control and Payment of Reimbursement to Health Service Providers database for all 80 813 deceased people in Norway within 2012-13. Outcomes were analyzed with logistic regression and negative binomial multilevel mixed-effect models. Overall, 1% of people received GP home visits in Week 13 and 4.6% in the last week before death. During the last 4 weeks of life, 9.2% received one or more GP home visits. Altogether, 6.6% received one or more home visits when the GP had one or more interdisciplinary collaborations during the last 4 weeks, of which <3% died at home. GP office consultations decreased towards the end of life. The likelihood of home death versus another location increased in relation to GP home visits [one home visit odds ratio (OR) 1.92, confidence interval (CI) 1.71-2.15; two or more OR 3.49, CI 3.08-3.96] and GP interdisciplinary collaboration (one contact OR 1.76, CI 1.59-1.96; two or more OR 2.52, CI 2.32-2.74). GPs play a role in enabling people to die at home by performing home visits and collaborating with other health care personnel. Only a minority received such services in Norway.

Sections du résumé

BACKGROUND
General practitioners (GPs) may play an important role in providing end-of-life care to community-dwelling people.
OBJECTIVE
To investigate patients' contacts with GPs, GPs' interdisciplinary collaboration, out-of-hours services and hospitalizations in the last 13 weeks of life and associations with dying at home. Second, investigate whether GP contacts were associated with fewer out-of-hours contacts or days hospitalized.
METHODS
Individually linked data from the Norwegian Cause of Death Registry, Norwegian Patient Registry, Statistics Norway and Control and Payment of Reimbursement to Health Service Providers database for all 80 813 deceased people in Norway within 2012-13. Outcomes were analyzed with logistic regression and negative binomial multilevel mixed-effect models.
RESULTS
Overall, 1% of people received GP home visits in Week 13 and 4.6% in the last week before death. During the last 4 weeks of life, 9.2% received one or more GP home visits. Altogether, 6.6% received one or more home visits when the GP had one or more interdisciplinary collaborations during the last 4 weeks, of which <3% died at home. GP office consultations decreased towards the end of life. The likelihood of home death versus another location increased in relation to GP home visits [one home visit odds ratio (OR) 1.92, confidence interval (CI) 1.71-2.15; two or more OR 3.49, CI 3.08-3.96] and GP interdisciplinary collaboration (one contact OR 1.76, CI 1.59-1.96; two or more OR 2.52, CI 2.32-2.74).
CONCLUSIONS
GPs play a role in enabling people to die at home by performing home visits and collaborating with other health care personnel. Only a minority received such services in Norway.

Identifiants

pubmed: 31995182
pii: 5717352
doi: 10.1093/fampra/cmz059
pmc: PMC7377342
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-347

Subventions

Organisme : NIA NIH HHS
ID : P30 AG021342
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG047891
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Références

BMJ Support Palliat Care. 2018 Jul 25;:
pubmed: 30045939
Palliat Med. 2017 Dec;31(10):932-945
pubmed: 28429629
BMC Palliat Care. 2013 Feb 15;12:7
pubmed: 23414145
Int J Family Med. 2015;2015:952314
pubmed: 26413319
BMC Fam Pract. 2010 Sep 15;11:66
pubmed: 20843334
Palliat Med. 2017 Jun;31(6):526-536
pubmed: 27683475
BMC Health Serv Res. 2019 Oct 15;19(1):698
pubmed: 31615500
BMJ Open. 2019 Jan 21;9(1):e025180
pubmed: 30670524
Scand J Prim Health Care. 2016 Dec;34(4):420-427
pubmed: 27822976
Br J Gen Pract. 2018 Mar;68(668):116-117
pubmed: 29472206
Tidsskr Nor Laegeforen. 2015 Dec 01;135(22):2045-9
pubmed: 26627292
Br J Gen Pract. 2011 Jun;61(587):e371-8
pubmed: 21801517
PLoS One. 2013 Dec 30;8(12):e84440
pubmed: 24386381
Tidsskr Nor Laegeforen. 2018 May 08;138(8):
pubmed: 29737771
Palliat Med. 2012 Mar;26(2):102-7
pubmed: 22258367
J Palliat Care. 2014 Autumn;30(3):141-50
pubmed: 25265737
BMC Fam Pract. 2013 Jul 22;14:104
pubmed: 23870615
BMC Palliat Care. 2016 Jun 02;15:52
pubmed: 27255464
Palliat Med. 2014 Feb;28(2):176-83
pubmed: 23779252
Palliat Med. 2016 Jan;30(1):64-74
pubmed: 26036688
BMC Palliat Care. 2018 May 2;17(1):69
pubmed: 29720154
Scand J Prim Health Care. 2010 Sep;28(3):138-45
pubmed: 20698730
Palliat Med. 2014 Oct;28(9):1081-98
pubmed: 24821710
BMJ. 2019 Apr 18;365:l1827
pubmed: 31000501
J Palliat Med. 2018 Jan;21(S1):S37-S44
pubmed: 29283868
J Pain Palliat Care Pharmacother. 2014 Jun;28(2):130-4
pubmed: 24779434
Support Care Cancer. 2014 Mar;22(3):645-52
pubmed: 24146344
BMJ Support Palliat Care. 2018 Dec;8(4):411-420
pubmed: 29353252
J Clin Oncol. 2010 May 1;28(13):2267-73
pubmed: 20351336
Palliat Med. 2018 Feb;32(2):376-383
pubmed: 28829222
J Palliat Med. 2008 Sep;11(7):980-5
pubmed: 18788958

Auteurs

Camilla Kjellstadli (C)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Heather Allore (H)

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.

Bettina S Husebo (BS)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Municipality of Bergen, Bergen, Norway.

Elisabeth Flo (E)

Department of Clinical Psychology, University of Bergen, Bergen, Norway.

Hogne Sandvik (H)

National Centre for Emergency Primary Health Care, NORCE Norwegian Research Centre, Bergen, Norway.

Steinar Hunskaar (S)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
National Centre for Emergency Primary Health Care, NORCE Norwegian Research Centre, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH